Associations - TSC2 mutation

BIOMARKER:

TSC2 mutation

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

TSC2 mutation TSC2 mutation	Peripheral T-cell Lymphoma Peripheral T-cell Lymphoma	copanlisib Sensitive: C3 – Early Trials copanlisib Sensitive : C3
TSC2 mutation TSC2 mutation	Endometrial Cancer Endometrial Cancer	temsirolimus Sensitive: C3 – Early Trials temsirolimus Sensitive : C3
TSC2 mutation TSC2 mutation	Renal Cell Carcinoma RCC	everolimus Sensitive: C3 – Early Trials everolimus Sensitive : C3
TSC2 mutation TSC2 mutation	Renal Cell Carcinoma RCC	temsirolimus Sensitive: C3 – Early Trials temsirolimus Sensitive : C3
TSC2 mutation TSC2 mutation	Renal Cell Carcinoma RCC	mTOR inhibitor Sensitive: C3 – Early Trials mTOR inhibitor Sensitive : C3